Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 654 entries
Sorted by: Best Match Show Resources per page
Detailed polyphenolic profiling of Annurca apple (M. pumila Miller cv Annurca) by a combination of RP-UHPLC and HILIC, both hyphenated to IT-TOF mass spectrometry.

Food research international (Ottawa, Ont.)

Sommella E, Pepe G, Pagano F, Ostacolo C, Tenore GC, Russo MT, Novellino E, Manfra M, Campiglia P.
PMID: 28455027
Food Res Int. 2015 Oct;76:466-477. doi: 10.1016/j.foodres.2015.05.044. Epub 2015 May 29.

Annurca apple, a Southern Italian cultivar, possesses not only a particular taste and flavor, different from other types of apple, but also several healthy properties. With the aim to thoroughly elucidate the polyphenolic profile of this variety, listed as...

Cite
Sommella E, Pepe G, Pagano F, et al. Detailed polyphenolic profiling of Annurca apple (M. pumila Miller cv Annurca) by a combination of RP-UHPLC and HILIC, both hyphenated to IT-TOF mass spectrometry. Food Res Int. 2015;76:466-477doi: 10.1016/j.foodres.2015.05.044.
Sommella, E., Pepe, G., Pagano, F., Ostacolo, C., Tenore, G. C., Russo, M. T., Novellino, E., Manfra, M., & Campiglia, P. (2015). Detailed polyphenolic profiling of Annurca apple (M. pumila Miller cv Annurca) by a combination of RP-UHPLC and HILIC, both hyphenated to IT-TOF mass spectrometry. Food research international (Ottawa, Ont.), 76466-477. https://doi.org/10.1016/j.foodres.2015.05.044
Sommella, Eduardo, et al. "Detailed polyphenolic profiling of Annurca apple (M. pumila Miller cv Annurca) by a combination of RP-UHPLC and HILIC, both hyphenated to IT-TOF mass spectrometry." Food research international (Ottawa, Ont.) vol. 76 (2015): 466-477. doi: https://doi.org/10.1016/j.foodres.2015.05.044
Sommella E, Pepe G, Pagano F, Ostacolo C, Tenore GC, Russo MT, Novellino E, Manfra M, Campiglia P. Detailed polyphenolic profiling of Annurca apple (M. pumila Miller cv Annurca) by a combination of RP-UHPLC and HILIC, both hyphenated to IT-TOF mass spectrometry. Food Res Int. 2015 Oct;76:466-477. doi: 10.1016/j.foodres.2015.05.044. Epub 2015 May 29. PMID: 28455027.
Copy Download .nbib Format: NLM
Management of neutropenic patients in the intensive care unit (NEWBORNS EXCLUDED) recommendations from an expert panel from the French Intensive Care Society (SRLF) with the French Group for Pediatric Intensive Care Emergencies (GFRUP), the French Society of Anesthesia and Intensive Care (SFAR), the French Society of Hematology (SFH), the French Society for Hospital Hygiene (SF2H), and the French Infectious Diseases Society (SPILF).

Annals of intensive care

Schnell D, Azoulay E, Benoit D, Clouzeau B, Demaret P, Ducassou S, Frange P, Lafaurie M, Legrand M, Meert AP, Mokart D, Naudin J, Pene F, Rabbat A, Raffoux E, Ribaud P, Richard JC, Vincent F, Zahar JR, Darmon M.
PMID: 27638133
Ann Intensive Care. 2016 Dec;6(1):90. doi: 10.1186/s13613-016-0189-6. Epub 2016 Sep 15.

Neutropenia is defined by either an absolute or functional defect (acute myeloid leukemia or myelodysplastic syndrome) of polymorphonuclear neutrophils and is associated with high risk of specific complications that may require intensive care unit (ICU) admission. Specificities in the...

Cite
Schnell D, Azoulay E, Benoit D, et al. Management of neutropenic patients in the intensive care unit (NEWBORNS EXCLUDED) recommendations from an expert panel from the French Intensive Care Society (SRLF) with the French Group for Pediatric Intensive Care Emergencies (GFRUP), the French Society of Anesthesia and Intensive Care (SFAR), the French Society of Hematology (SFH), the French Society for Hospital Hygiene (SF2H), and the French Infectious Diseases Society (SPILF). Ann Intensive Care. 2016;6(1):90doi: 10.1186/s13613-016-0189-6.
Schnell, D., Azoulay, E., Benoit, D., Clouzeau, B., Demaret, P., Ducassou, S., Frange, P., Lafaurie, M., Legrand, M., Meert, A. P., Mokart, D., Naudin, J., Pene, F., Rabbat, A., Raffoux, E., Ribaud, P., Richard, J. C., Vincent, F., Zahar, J. R., & Darmon, M. (2016). Management of neutropenic patients in the intensive care unit (NEWBORNS EXCLUDED) recommendations from an expert panel from the French Intensive Care Society (SRLF) with the French Group for Pediatric Intensive Care Emergencies (GFRUP), the French Society of Anesthesia and Intensive Care (SFAR), the French Society of Hematology (SFH), the French Society for Hospital Hygiene (SF2H), and the French Infectious Diseases Society (SPILF). Annals of intensive care, 6(1), 90. https://doi.org/10.1186/s13613-016-0189-6
Schnell, David, et al. "Management of neutropenic patients in the intensive care unit (NEWBORNS EXCLUDED) recommendations from an expert panel from the French Intensive Care Society (SRLF) with the French Group for Pediatric Intensive Care Emergencies (GFRUP), the French Society of Anesthesia and Intensive Care (SFAR), the French Society of Hematology (SFH), the French Society for Hospital Hygiene (SF2H), and the French Infectious Diseases Society (SPILF)." Annals of intensive care vol. 6,1 (2016): 90. doi: https://doi.org/10.1186/s13613-016-0189-6
Schnell D, Azoulay E, Benoit D, Clouzeau B, Demaret P, Ducassou S, Frange P, Lafaurie M, Legrand M, Meert AP, Mokart D, Naudin J, Pene F, Rabbat A, Raffoux E, Ribaud P, Richard JC, Vincent F, Zahar JR, Darmon M. Management of neutropenic patients in the intensive care unit (NEWBORNS EXCLUDED) recommendations from an expert panel from the French Intensive Care Society (SRLF) with the French Group for Pediatric Intensive Care Emergencies (GFRUP), the French Society of Anesthesia and Intensive Care (SFAR), the French Society of Hematology (SFH), the French Society for Hospital Hygiene (SF2H), and the French Infectious Diseases Society (SPILF). Ann Intensive Care. 2016 Dec;6(1):90. doi: 10.1186/s13613-016-0189-6. Epub 2016 Sep 15. PMID: 27638133; PMCID: PMC5025409.
Copy Download .nbib Format: NLM
Timescales of mixing and of chemistry: general discussion.

Faraday discussions

Pope F, Monks PS, Kleffmann J, Tomlin A, Whalley L, Heard D, Rickard A, Bloss W, Harrison R, Madronich S, McFiggans G, Donahue NM, Molteni U, Wahner A, Brune W, Querol X, Hou S, Tong S, Kim S.
PMID: 27374206
Faraday Discuss. 2016 Jul 18;189:253-76. doi: 10.1039/C6FD90023B.

No abstract available.

Cite
Pope F, Monks PS, Kleffmann J, et al. Timescales of mixing and of chemistry: general discussion. Faraday Discuss. 2016;189:253-76doi: 10.1039/C6FD90023B.
Pope, F., Monks, P. S., Kleffmann, J., Tomlin, A., Whalley, L., Heard, D., Rickard, A., Bloss, W., Harrison, R., Madronich, S., McFiggans, G., Donahue, N. M., Molteni, U., Wahner, A., Brune, W., Querol, X., Hou, S., Tong, S., & Kim, S. (2016). Timescales of mixing and of chemistry: general discussion. Faraday discussions, 189253-76. https://doi.org/10.1039/C6FD90023B
Pope, Francis, et al. "Timescales of mixing and of chemistry: general discussion." Faraday discussions vol. 189 (2016): 253-76. doi: https://doi.org/10.1039/C6FD90023B
Pope F, Monks PS, Kleffmann J, Tomlin A, Whalley L, Heard D, Rickard A, Bloss W, Harrison R, Madronich S, McFiggans G, Donahue NM, Molteni U, Wahner A, Brune W, Querol X, Hou S, Tong S, Kim S. Timescales of mixing and of chemistry: general discussion. Faraday Discuss. 2016 Jul 18;189:253-76. doi: 10.1039/C6FD90023B. PMID: 27374206.
Copy Download .nbib Format: NLM
Characterization of Shiga Toxin Subtypes and Virulence Genes in Porcine Shiga Toxin-Producing Escherichia coli.

Frontiers in microbiology

Baranzoni GM, Fratamico PM, Gangiredla J, Patel I, Bagi LK, Delannoy S, Fach P, Boccia F, Anastasio A, Pepe T.
PMID: 27148249
Front Microbiol. 2016 Apr 21;7:574. doi: 10.3389/fmicb.2016.00574. eCollection 2016.

Similar to ruminants, swine have been shown to be a reservoir for Shiga toxin-producing Escherichia coli (STEC), and pork products have been linked with outbreaks associated with STEC O157 and O111:H-. STEC strains, isolated in a previous study from...

Cite
Baranzoni GM, Fratamico PM, Gangiredla J, et al. Characterization of Shiga Toxin Subtypes and Virulence Genes in Porcine Shiga Toxin-Producing Escherichia coli. Front Microbiol. 2016;7:574doi: 10.3389/fmicb.2016.00574.
Baranzoni, G. M., Fratamico, P. M., Gangiredla, J., Patel, I., Bagi, L. K., Delannoy, S., Fach, P., Boccia, F., Anastasio, A., & Pepe, T. (2016). Characterization of Shiga Toxin Subtypes and Virulence Genes in Porcine Shiga Toxin-Producing Escherichia coli. Frontiers in microbiology, 7574. https://doi.org/10.3389/fmicb.2016.00574
Baranzoni, Gian Marco, et al. "Characterization of Shiga Toxin Subtypes and Virulence Genes in Porcine Shiga Toxin-Producing Escherichia coli." Frontiers in microbiology vol. 7 (2016): 574. doi: https://doi.org/10.3389/fmicb.2016.00574
Baranzoni GM, Fratamico PM, Gangiredla J, Patel I, Bagi LK, Delannoy S, Fach P, Boccia F, Anastasio A, Pepe T. Characterization of Shiga Toxin Subtypes and Virulence Genes in Porcine Shiga Toxin-Producing Escherichia coli. Front Microbiol. 2016 Apr 21;7:574. doi: 10.3389/fmicb.2016.00574. eCollection 2016. PMID: 27148249; PMCID: PMC4838603.
Copy Download .nbib Format: NLM
Ratios of central venous-to-arterial carbon dioxide content or tension to arteriovenous oxygen content are better markers of global anaerobic metabolism than lactate in septic shock patients.

Annals of intensive care

Mallat J, Lemyze M, Meddour M, Pepy F, Gasan G, Barrailler S, Durville E, Temime J, Vangrunderbeeck N, Tronchon L, Vallet B, Thevenin D.
PMID: 26842697
Ann Intensive Care. 2016 Dec;6(1):10. doi: 10.1186/s13613-016-0110-3. Epub 2016 Feb 03.

BACKGROUND: To evaluate the ability of the central venous-to-arterial CO2 content and tension differences to arteriovenous oxygen content difference ratios (∆ContCO2/∆ContO2 and ∆PCO2/∆ContO2, respectively), blood lactate concentration, and central venous oxygen saturation (ScvO2) to detect the presence of global...

Cite
Mallat J, Lemyze M, Meddour M, et al. Ratios of central venous-to-arterial carbon dioxide content or tension to arteriovenous oxygen content are better markers of global anaerobic metabolism than lactate in septic shock patients. Ann Intensive Care. 2016;6(1):10doi: 10.1186/s13613-016-0110-3.
Mallat, J., Lemyze, M., Meddour, M., Pepy, F., Gasan, G., Barrailler, S., Durville, E., Temime, J., Vangrunderbeeck, N., Tronchon, L., Vallet, B., & Thevenin, D. (2016). Ratios of central venous-to-arterial carbon dioxide content or tension to arteriovenous oxygen content are better markers of global anaerobic metabolism than lactate in septic shock patients. Annals of intensive care, 6(1), 10. https://doi.org/10.1186/s13613-016-0110-3
Mallat, Jihad, et al. "Ratios of central venous-to-arterial carbon dioxide content or tension to arteriovenous oxygen content are better markers of global anaerobic metabolism than lactate in septic shock patients." Annals of intensive care vol. 6,1 (2016): 10. doi: https://doi.org/10.1186/s13613-016-0110-3
Mallat J, Lemyze M, Meddour M, Pepy F, Gasan G, Barrailler S, Durville E, Temime J, Vangrunderbeeck N, Tronchon L, Vallet B, Thevenin D. Ratios of central venous-to-arterial carbon dioxide content or tension to arteriovenous oxygen content are better markers of global anaerobic metabolism than lactate in septic shock patients. Ann Intensive Care. 2016 Dec;6(1):10. doi: 10.1186/s13613-016-0110-3. Epub 2016 Feb 03. PMID: 26842697; PMCID: PMC4740480.
Copy Download .nbib Format: NLM
Identification of a novel truncating mutation in PALB2 gene by a multigene sequencing panel for mutational screening of breast cancer risk-associated and related genes.

Journal of clinical laboratory analysis

Guacci A, Cordella A, Rocco T, Giurato G, Nassa G, Rizzo F, Carlomagno C, Pepe S, Tarallo R, Weisz A.
PMID: 29484706
J Clin Lab Anal. 2018 Jul;32(6):e22418. doi: 10.1002/jcla.22418. Epub 2018 Feb 27.

BACKGROUND: Breast cancer (BC) is the most common neoplasm in women, with 5%-10% patients showing a familial predisposition, where germline mutations in BRCA1/BRCA2 genes are found in -20% of cases. Next-generation sequencing (NGS) is among the best available options...

Cite
Guacci A, Cordella A, Rocco T, et al. Identification of a novel truncating mutation in PALB2 gene by a multigene sequencing panel for mutational screening of breast cancer risk-associated and related genes. J Clin Lab Anal. 2018;32(6):e22418doi: 10.1002/jcla.22418.
Guacci, A., Cordella, A., Rocco, T., Giurato, G., Nassa, G., Rizzo, F., Carlomagno, C., Pepe, S., Tarallo, R., & Weisz, A. (2018). Identification of a novel truncating mutation in PALB2 gene by a multigene sequencing panel for mutational screening of breast cancer risk-associated and related genes. Journal of clinical laboratory analysis, 32(6), e22418. https://doi.org/10.1002/jcla.22418
Guacci, Anna, et al. "Identification of a novel truncating mutation in PALB2 gene by a multigene sequencing panel for mutational screening of breast cancer risk-associated and related genes." Journal of clinical laboratory analysis vol. 32,6 (2018): e22418. doi: https://doi.org/10.1002/jcla.22418
Guacci A, Cordella A, Rocco T, Giurato G, Nassa G, Rizzo F, Carlomagno C, Pepe S, Tarallo R, Weisz A. Identification of a novel truncating mutation in PALB2 gene by a multigene sequencing panel for mutational screening of breast cancer risk-associated and related genes. J Clin Lab Anal. 2018 Jul;32(6):e22418. doi: 10.1002/jcla.22418. Epub 2018 Feb 27. PMID: 29484706; PMCID: PMC6817177.
Copy Download .nbib Format: NLM
Addition of erlotinib to fluoropyrimidine-oxaliplatin-based chemotherapy with or without bevacizumab: Two sequential phase I trials.

Experimental and therapeutic medicine

Carlomagno C, Daniele G, Bianco R, Marciano R, Damiano V, Matano E, Nappi L, Pepe S, DE Placido S, Tortora G.
PMID: 22977524
Exp Ther Med. 2011 May;2(3):449-455. doi: 10.3892/etm.2011.218. Epub 2011 Feb 25.

The combination of EGFR inhibitors and anti-angiogenic drugs has a strong pre-clinical rationale, yet its use has produced controversial clinical results. We conducted two sequential phase I trials to evaluate the feasibility and the recommended dose of erlotinib when...

Cite
Carlomagno C, Daniele G, Bianco R, et al. Addition of erlotinib to fluoropyrimidine-oxaliplatin-based chemotherapy with or without bevacizumab: Two sequential phase I trials. Exp Ther Med. 2011;2(3):449-455doi: 10.3892/etm.2011.218.
Carlomagno, C., Daniele, G., Bianco, R., Marciano, R., Damiano, V., Matano, E., Nappi, L., Pepe, S., DE Placido, S., & Tortora, G. (2011). Addition of erlotinib to fluoropyrimidine-oxaliplatin-based chemotherapy with or without bevacizumab: Two sequential phase I trials. Experimental and therapeutic medicine, 2(3), 449-455. https://doi.org/10.3892/etm.2011.218
Carlomagno, Chiara, et al. "Addition of erlotinib to fluoropyrimidine-oxaliplatin-based chemotherapy with or without bevacizumab: Two sequential phase I trials." Experimental and therapeutic medicine vol. 2,3 (2011): 449-455. doi: https://doi.org/10.3892/etm.2011.218
Carlomagno C, Daniele G, Bianco R, Marciano R, Damiano V, Matano E, Nappi L, Pepe S, DE Placido S, Tortora G. Addition of erlotinib to fluoropyrimidine-oxaliplatin-based chemotherapy with or without bevacizumab: Two sequential phase I trials. Exp Ther Med. 2011 May;2(3):449-455. doi: 10.3892/etm.2011.218. Epub 2011 Feb 25. PMID: 22977524; PMCID: PMC3440709.
Copy Download .nbib Format: NLM
Romiplostim Cost Per Response In Itp Treatment In the Brazilian Health Care System.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research

Pepe C, Teich V, Coutinho MB, Almeida S.
PMID: 27201674
Value Health. 2014 Nov;17(7):A529. doi: 10.1016/j.jval.2014.08.1677. Epub 2014 Oct 26.

No abstract available.

Cite
Pepe C, Teich V, Coutinho MB, et al. Romiplostim Cost Per Response In Itp Treatment In the Brazilian Health Care System. Value Health. 2014;17(7):A529doi: 10.1016/j.jval.2014.08.1677.
Pepe, C., Teich, V., Coutinho, M. B., & Almeida, S. (2014). Romiplostim Cost Per Response In Itp Treatment In the Brazilian Health Care System. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, 17(7), A529. https://doi.org/10.1016/j.jval.2014.08.1677
Pepe, C, et al. "Romiplostim Cost Per Response In Itp Treatment In the Brazilian Health Care System." Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research vol. 17,7 (2014): A529. doi: https://doi.org/10.1016/j.jval.2014.08.1677
Pepe C, Teich V, Coutinho MB, Almeida S. Romiplostim Cost Per Response In Itp Treatment In the Brazilian Health Care System. Value Health. 2014 Nov;17(7):A529. doi: 10.1016/j.jval.2014.08.1677. Epub 2014 Oct 26. PMID: 27201674.
Copy Download .nbib Format: NLM
Tricriticalities and Quantum Phases in Spin-Orbit-Coupled Spin-1 Bose Gases.

Physical review letters

Martone GI, Pepe FV, Facchi P, Pascazio S, Stringari S.
PMID: 27689283
Phys Rev Lett. 2016 Sep 16;117(12):125301. doi: 10.1103/PhysRevLett.117.125301. Epub 2016 Sep 16.

We study the zero-temperature phase diagram of a spin-orbit-coupled Bose-Einstein condensate of spin 1, with equally weighted Rashba and Dresselhaus couplings. Depending on the antiferromagnetic or ferromagnetic nature of the interactions, we find three kinds of striped phases with...

Cite
Martone GI, Pepe FV, Facchi P, et al. Tricriticalities and Quantum Phases in Spin-Orbit-Coupled Spin-1 Bose Gases. Phys Rev Lett. 2016;117(12):125301doi: 10.1103/PhysRevLett.117.125301.
Martone, G. I., Pepe, F. V., Facchi, P., Pascazio, S., & Stringari, S. (2016). Tricriticalities and Quantum Phases in Spin-Orbit-Coupled Spin-1 Bose Gases. Physical review letters, 117(12), 125301. https://doi.org/10.1103/PhysRevLett.117.125301
Martone, Giovanni I, et al. "Tricriticalities and Quantum Phases in Spin-Orbit-Coupled Spin-1 Bose Gases." Physical review letters vol. 117,12 (2016): 125301. doi: https://doi.org/10.1103/PhysRevLett.117.125301
Martone GI, Pepe FV, Facchi P, Pascazio S, Stringari S. Tricriticalities and Quantum Phases in Spin-Orbit-Coupled Spin-1 Bose Gases. Phys Rev Lett. 2016 Sep 16;117(12):125301. doi: 10.1103/PhysRevLett.117.125301. Epub 2016 Sep 16. PMID: 27689283.
Copy Download .nbib Format: NLM
The molecular characterization by SSRs reveals a new South Italian kinship and the origin of the cultivar Uva di Troia.

SpringerPlus

Bergamini C, Perniola R, Cardone MF, Gasparro M, Pepe R, Caputo AR, Antonacci D.
PMID: 27652135
Springerplus. 2016 Sep 14;5(1):1562. doi: 10.1186/s40064-016-3228-8. eCollection 2016.

Vitis vinifera L. varieties were spread through cuttings following historic migrations of people, trades, or after biological crises due to pests outbreaks. Some today's varieties could be more than a 1000 years old and, although over the centuries these...

Cite
Bergamini C, Perniola R, Cardone MF, et al. The molecular characterization by SSRs reveals a new South Italian kinship and the origin of the cultivar Uva di Troia. Springerplus. 2016;5(1):1562doi: 10.1186/s40064-016-3228-8.
Bergamini, C., Perniola, R., Cardone, M. F., Gasparro, M., Pepe, R., Caputo, A. R., & Antonacci, D. (2016). The molecular characterization by SSRs reveals a new South Italian kinship and the origin of the cultivar Uva di Troia. SpringerPlus, 5(1), 1562. https://doi.org/10.1186/s40064-016-3228-8
Bergamini, C, et al. "The molecular characterization by SSRs reveals a new South Italian kinship and the origin of the cultivar Uva di Troia." SpringerPlus vol. 5,1 (2016): 1562. doi: https://doi.org/10.1186/s40064-016-3228-8
Bergamini C, Perniola R, Cardone MF, Gasparro M, Pepe R, Caputo AR, Antonacci D. The molecular characterization by SSRs reveals a new South Italian kinship and the origin of the cultivar Uva di Troia. Springerplus. 2016 Sep 14;5(1):1562. doi: 10.1186/s40064-016-3228-8. eCollection 2016. PMID: 27652135; PMCID: PMC5023643.
Copy Download .nbib Format: NLM
Identification of Plant Extracts that Inhibit the Formation of Diabetes-Linked IAPP Amyloid.

Journal of herbal medicine

Fuentes AL, Hennessy K, Pascual J, Pepe N, Wang I, Santiago A, Chaggan C, Martinez J, Rivera E, Cota P, Cunha C, Nogaj LA, Moffet DA.
PMID: 27042401
J Herb Med. 2016 Mar;6(1):37-41. doi: 10.1016/j.hermed.2015.11.001.

The extracts of 27 vegetables, spices and herbs were screened for their functional ability to inhibit the aggregation of islet amyloid polypeptide (IAPP, amylin) into toxic amyloid aggregates. The aggregation of IAPP has been directly linked to the death...

Cite
Fuentes AL, Hennessy K, Pascual J, et al. Identification of Plant Extracts that Inhibit the Formation of Diabetes-Linked IAPP Amyloid. J Herb Med. 2016;6(1):37-41doi: 10.1016/j.hermed.2015.11.001.
Fuentes, A. L., Hennessy, K., Pascual, J., Pepe, N., Wang, I., Santiago, A., Chaggan, C., Martinez, J., Rivera, E., Cota, P., Cunha, C., Nogaj, L. A., & Moffet, D. A. (2016). Identification of Plant Extracts that Inhibit the Formation of Diabetes-Linked IAPP Amyloid. Journal of herbal medicine, 6(1), 37-41. https://doi.org/10.1016/j.hermed.2015.11.001
Fuentes, Ana Lucia, et al. "Identification of Plant Extracts that Inhibit the Formation of Diabetes-Linked IAPP Amyloid." Journal of herbal medicine vol. 6,1 (2016): 37-41. doi: https://doi.org/10.1016/j.hermed.2015.11.001
Fuentes AL, Hennessy K, Pascual J, Pepe N, Wang I, Santiago A, Chaggan C, Martinez J, Rivera E, Cota P, Cunha C, Nogaj LA, Moffet DA. Identification of Plant Extracts that Inhibit the Formation of Diabetes-Linked IAPP Amyloid. J Herb Med. 2016 Mar;6(1):37-41. doi: 10.1016/j.hermed.2015.11.001. PMID: 27042401; PMCID: PMC4815265.
Copy Download .nbib Format: NLM
The evagination of the genital imaginal discs ofDrosophila melanogaster : II. Morphogenesis of the intersexual genital disc of the mutantdoublesex-dominant (dsx .

Wilhelm Roux's archives of developmental biology

Epper F.
PMID: 28305516
Wilehm Roux Arch Dev Biol. 1983 Sep;192(5):280-284. doi: 10.1007/BF00848661.

Morphogenetic movements of the intersexual genital disc of thedoublesex-dominant mutant ofDrosophila melanogaster were followed during metamorphosis. Intersexual genital discs contain well developed genital primordia of both sexes as well as an anal primordium, and all of these primordia evaginate...

Cite
Epper F. The evagination of the genital imaginal discs ofDrosophila melanogaster : II. Morphogenesis of the intersexual genital disc of the mutantdoublesex-dominant (dsx . Wilehm Roux Arch Dev Biol. 1983;192(5):280-284doi: 10.1007/BF00848661.
Epper, F. (1983). The evagination of the genital imaginal discs ofDrosophila melanogaster : II. Morphogenesis of the intersexual genital disc of the mutantdoublesex-dominant (dsx . Wilhelm Roux's archives of developmental biology, 192(5), 280-284. https://doi.org/10.1007/BF00848661
Epper, Felix. "The evagination of the genital imaginal discs ofDrosophila melanogaster : II. Morphogenesis of the intersexual genital disc of the mutantdoublesex-dominant (dsx ." Wilhelm Roux's archives of developmental biology vol. 192,5 (1983): 280-284. doi: https://doi.org/10.1007/BF00848661
Epper F. The evagination of the genital imaginal discs ofDrosophila melanogaster : II. Morphogenesis of the intersexual genital disc of the mutantdoublesex-dominant (dsx . Wilehm Roux Arch Dev Biol. 1983 Sep;192(5):280-284. doi: 10.1007/BF00848661. PMID: 28305516.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 654 entries